The global Joint Pain Injections Market size is estimated to generate revenues of more than USD 7.59 billion by 2030, growing at a CAGR of around 6.9% from 2022 to 2030
The report covers SWOT analysis, market valuation, competitive spectrum,
regional share, and revenue predictions. The report offers an analysis of the global joint
pain injections Market for the period 2017 to 2030, wherein 2022 to 2030 is the
forecast period and 2021 is considered as the base year.
The wide application portfolio of joint pain injections market is one of
factors driving the growth of market worldwide. The global market is moderately
competitive with a blend of global and regional players. The markets key
players invest significantly in R and D to enhance their offerings. The entire
ecosystem is composed of multiple participants. Every participant of the
ecosystem is an equal contributor to the growth of global market.
Why should
you invest in this report?
If you are aiming to enter the global joint
pain injections Market, this report is a comprehensive guide that provides
crystal clear insights into this niche market. All the major application areas
for joint pain injections are covered in this report and information is given
on the important regions of the world where this market is likely to boom
during the forecast period of 2022-2030, so that you can plan your strategies
to enter this market accordingly. Besides, through this report, you can have a
complete grasp of the level of competition you will be facing in this hugely
competitive market and if you are an established player in this market already,
this report will help you gauge the strategies that your competitors have
adopted to stay as market leaders in this market. For new entrants to this
market, the voluminous data provided in this report is invaluable.
Report Structure:
- pertinent
market numbers of the global joint pain injections market along with the
CAGR for the forecast period 2022-2030
- detailed
definitions of different types of joint pain injections, which gives
clarity about what this market is all about and also defines the scope of
this report
- macroeconomic
factors influencing the global joint pain injections market, along with
market opportunity analysis
- key
trends likely to impact the global joint pain injections market
- PESTLE
analysis of all the regions as per the market taxonomy
- Porter’s
Five Force Analysis of all the regions as given in the market taxonomy
Global market analysis and forecast:
- the
global joint pain injections market analysis and forecast by product type,
by application, by region and others
- key
market metrics such as the BPS analysis, year-on-year growth rates,
absolute dollar opportunity and market attractiveness analysis of the
global joint pain injections market
Regional market analysis and forecast:
- Regional
joint pain injections market analysis and forecast
- Regional
market dynamics including the drivers, restraints and trends applicable
across different regions in the joint pain injections market along with
factors encouraging the growth of this market as well as the factors
hampering the growth of this market
- Regional
trends – both long term and short term
View Full Report@
https://www.precedenceresearch.com/joint-pain-injections-market
Competitive landscape:
- the
competitive landscape of this global report
- information
on the various leading companies in the global market
- a
dashboard view of the key companies operating in the global market along
with their important information and broad strategy adopted to stay as
leaders in the global market
- key
company profiles along with important information such as company details,
company description, product portfolio along with key developments concerning
the company and strategic analysis
Some of the prominent players in joint pain
injections market include:
- Anika Therapeutics
Inc.
- Bioventus
- Ferring
Pharmaceuticals Inc.
- Sanofi
- Zimmer Biomet Holdings
Inc.
- Allergen Plc.
- Pfizer Inc.
- Chugai Pharmaceutical
Co. Ltd
- SEIKAGAKU Corporation
- Ferring B.V.
Market Segmentation:
By Injection Type
- Corticosteroid
Injections
- Hyaluronic Acid
Injections
- Platelet-rich Plasma
Injections
- Placental tissue
matrix (PTM) Injections
By Joint Type
- Knee and Ankle
- Hip
- Shoulder and Elbow
- Spinal Joints
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Product Type
- Pre-filled injections
- Vials
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
In this report, historical data, primary
responses and public domain data has been thoroughly analyzed to infer the
market size. Revenue of companies operating in the global market has been
benchmarked to ascertain the market size for the base year. Macroeconomic
indicators such as GDP and industry growth have been considered to determine
the market size for the forecast period. The historical growth trend of end-use
industries, market participants’ performance, as well as the present
macro-economic outlook has been taken into consideration for estimating the
overall market trend forecast. This data is then validated using the
triangulation method and extensively scrutinized using advanced tools to garner
quantitative and qualitative insights into the global joint pain injections.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2.
Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions &
Limitations
Chapter 3.
Executive Summary
3.1. Market Snapshot
Chapter 4.
Market Variables and Scope
4.1. Introduction
4.2. Market
Classification and Scope
4.3. Industry Value
Chain Analysis
4.3.1. Raw Material
Procurement Analysis
4.3.2. Sales and
Distribution Channel Analysis
4.3.3. Downstream Buyer
Analysis
Chapter 5.
COVID 19 Impact on Joint Pain Injections Market
5.1. COVID-19
Landscape: Joint Pain Injections Industry Impact
5.2. COVID 19 - Impact
Assessment for the Industry
5.3. COVID 19 Impact:
Global Major Government Policy
5.4. Market Trends and
Opportunities in the COVID-19 Landscape
Chapter 6.
Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market
Restraints
6.1.3. Market
Opportunities
6.2. Porter’s Five
Forces Analysis
6.2.1. Bargaining power
of suppliers
6.2.2. Bargaining power
of buyers
6.2.3. Threat of
substitute
6.2.4. Threat of new
entrants
6.2.5. Degree of
competition
Chapter 7.
Competitive Landscape
7.1.1. Company Market
Share/Positioning Analysis
7.1.2. Key Strategies
Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of
Suppliers
7.1.3.2. List of Buyers
Chapter 8.
Global Joint Pain Injections Market, By Product
8.1. Joint Pain
Injections Market, by Product Type, 2021-2030
8.1.1. Pre-filled
injections
8.1.1.1. Market Revenue
and Forecast (2019-2030)
8.1.2. Vials
8.1.2.1. Market Revenue
and Forecast (2019-2030)
Chapter 9.
Global Joint Pain Injections Market, By Injection
9.1. Joint Pain
Injections Market, by Injection, 2021-2030
9.1.1. Corticosteroid
Injections
9.1.1.1. Market Revenue
and Forecast (2019-2030)
9.1.2. Hyaluronic Acid
Injections
9.1.2.1. Market Revenue
and Forecast (2019-2030)
9.1.3. Platelet-rich
Plasma Injections
9.1.3.1. Market Revenue
and Forecast (2019-2030)
9.1.4. Placental tissue
matrix (PTM) Injections
9.1.4.1. Market Revenue
and Forecast (2019-2030)
Chapter 10.
Global Joint Pain Injections Market, By Joint Type
10.1. Joint Pain
Injections Market, by Joint Type, 2021-2030
10.1.1. Knee and Ankle
10.1.1.1. Market
Revenue and Forecast (2019-2030)
10.1.2. Hip
10.1.2.1. Market
Revenue and Forecast (2019-2030)
10.1.3. Shoulder and
Elbow
10.1.3.1. Market
Revenue and Forecast (2019-2030)
10.1.4. Spinal Joints
10.1.4.1. Market
Revenue and Forecast (2019-2030)
10.1.5. Others
10.1.5.1. Market
Revenue and Forecast (2019-2030)
Chapter 11.
Global Joint Pain Injections Market, By Distribution Type
11.1. Joint Pain
Injections Market, by Distribution Type, 2021-2030
11.1.1. Hospital
Pharmacies
11.1.1.1. Market
Revenue and Forecast (2019-2030)
11.1.2. Retail
Pharmacies
11.1.2.1. Market
Revenue and Forecast (2019-2030)
11.1.3. Online
Pharmacies
11.1.3.1. Market
Revenue and Forecast (2019-2030)
Chapter 12.
Global Joint Pain Injections Market, Regional Estimates and Trend
Forecast
12.1. North America
12.1.1. Market Revenue
and Forecast, by Product (2019-2030)
12.1.2. Market Revenue
and Forecast, by Injection (2019-2030)
12.1.3. Market Revenue
and Forecast, by Joint Type (2019-2030)
12.1.4. Market Revenue
and Forecast, by Distribution Type (2019-2030)
12.1.5. U.S.
12.1.5.1. Market
Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.1.5.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.1.5.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.1.6. Rest of North
America
12.1.6.1. Market
Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.1.6.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.1.6.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.2. Europe
12.2.1. Market Revenue
and Forecast, by Product (2019-2030)
12.2.2. Market Revenue
and Forecast, by Injection (2019-2030)
12.2.3. Market Revenue
and Forecast, by Joint Type (2019-2030)
12.2.4. Market Revenue
and Forecast, by Distribution Type (2019-2030)
12.2.5. UK
12.2.5.1. Market
Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.2.5.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.2.5.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.2.6. Germany
12.2.6.1. Market
Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.2.6.3. Market Revenue
and Forecast, by Joint Type (2019-2030)
12.2.6.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.2.7. France
12.2.7.1. Market
Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.2.7.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.2.7.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market
Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.2.8.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.2.8.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.3. APAC
12.3.1. Market Revenue
and Forecast, by Product (2019-2030)
12.3.2. Market Revenue
and Forecast, by Injection (2019-2030)
12.3.3. Market Revenue
and Forecast, by Joint Type (2019-2030)
12.3.4. Market Revenue
and Forecast, by Distribution Type (2019-2030)
12.3.5. India
12.3.5.1. Market
Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.3.5.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.3.5.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.3.6. China
12.3.6.1. Market
Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.3.6.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.3.6.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.3.7. Japan
12.3.7.1. Market
Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.3.7.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.3.7.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market
Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.3.8.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.3.8.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.4. MEA
12.4.1. Market Revenue
and Forecast, by Product (2019-2030)
12.4.2. Market Revenue
and Forecast, by Injection (2019-2030)
12.4.3. Market Revenue
and Forecast, by Joint Type (2019-2030)
12.4.4. Market Revenue
and Forecast, by Distribution Type (2019-2030)
12.4.5. GCC
12.4.5.1. Market
Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.4.5.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.4.5.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.4.6. North Africa
12.4.6.1. Market
Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.4.6.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.4.6.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.4.7. South Africa
12.4.7.1. Market
Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.4.7.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.4.7.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market
Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.4.8.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.4.8.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.5. Latin America
12.5.1. Market Revenue
and Forecast, by Product (2019-2030)
12.5.2. Market Revenue
and Forecast, by Injection (2019-2030)
12.5.3. Market Revenue
and Forecast, by Joint Type (2019-2030)
12.5.4. Market Revenue
and Forecast, by Distribution Type (2019-2030)
12.5.5. Brazil
12.5.5.1. Market
Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.5.5.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.5.5.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market
Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market
Revenue and Forecast, by Injection (2019-2030)
12.5.6.3. Market
Revenue and Forecast, by Joint Type (2019-2030)
12.5.6.4. Market
Revenue and Forecast, by Distribution Type (2019-2030)
Chapter 13.
Company Profiles
13.1. Online Pharmacies
13.1.1. Company
Overview
13.1.2. Product
Offerings
13.1.3. Financial
Performance
13.1.4. Recent
Initiatives
13.2. Bioventus
13.2.1. Company
Overview
13.2.2. Product
Offerings
13.2.3. Financial
Performance
13.2.4. Recent
Initiatives
13.3. Ferring
Pharmaceuticals Inc.
13.3.1. Company
Overview
13.3.2. Product
Offerings
13.3.3. Financial
Performance
13.3.4. Recent
Initiatives
13.4. Sanofi
13.4.1. Company
Overview
13.4.2. Product
Offerings
13.4.3. Financial
Performance
13.4.4. Recent
Initiatives
13.5. Zimmer Biomet
Holdings Inc.
13.5.1. Company
Overview
13.5.2. Product
Offerings
13.5.3. Financial
Performance
13.5.4. Recent
Initiatives
13.6. Allergen Plc.
13.6.1. Company Overview
13.6.2. Product
Offerings
13.6.3. Financial
Performance
13.6.4. Recent
Initiatives
13.7. Pfizer Inc.
13.7.1. Company
Overview
13.7.2. Product
Offerings
13.7.3. Financial
Performance
13.7.4. Recent
Initiatives
13.8. Chugai
Pharmaceutical Co. Ltd
13.8.1. Company
Overview
13.8.2. Product
Offerings
13.8.3. Financial
Performance
13.8.4. Recent
Initiatives
13.9. SEIKAGAKU
Corporation
13.9.1. Company
Overview
13.9.2. Product
Offerings
13.9.3. Financial
Performance
13.9.4. Recent
Initiatives
13.10. Ferring B.V.
13.10.1. Company
Overview
13.10.2. Product
Offerings
13.10.3. Financial
Performance
13.10.4. Recent
Initiatives
Chapter 14.
Research Methodology
14.1. Primary Research
14.2. Secondary
Research
14.3. Assumptions
Chapter 15.
Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: http://www.marketstatsnews.com/
0 comments:
Post a Comment